OBJECTIVE: To evaluate the Milano-Torino staging (MiToS) and King\u27s staging systems as potential outcome measures for clinical trials in amyotrophic lateral sclerosis (ALS) by assessing these outcomes in FORTITUDE-ALS. METHODS: This was a RESULTS: The full analysis set consisted of 456 patients randomized 3:1 ( CONCLUSION: This exploratory analysis showed the feasibility of MiToS and King\u27s staging as potential outcome measures in ALS. Additional studies of these staging systems are needed to further explore their utility in ALS clinical trials
OBJECTIVE: Clinical stages in amyotrophic lateral sclerosis (ALS) can be measured using a simple sys...
Objective: It is important to explore the utility of clinical staging systems in the management of a...
International audienceAmyotrophic lateral sclerosis (ALS) is a heterogenous motoneuronal neurodegene...
Objective: To investigate and compare two ALS staging systems, King’s clinical staging and Milano-To...
International audienceBackground: Assessing clinical progression in amyotrophic lateral sclerosis (A...
Background and purpose: To compare two recently developed staging systems for amyotrophic lateral sc...
Background: Amyotrophic lateral sclerosis (ALS) shows considerable clinical heterogeneity, which aff...
Background: Amyotrophic lateral sclerosis (ALS) shows considerable clinical heterogeneity, which aff...
To investigate and compare two ALS staging systems, King's clinical staging and Milano-Torino (MiToS...
Objective: The choice of adequate proxy for long-term survival, the ultimate outcome in randomised c...
OBJECTIVE: Clinical stages in amyotrophic lateral sclerosis (ALS) can be measured using a simple sys...
Objective: It is important to explore the utility of clinical staging systems in the management of a...
International audienceAmyotrophic lateral sclerosis (ALS) is a heterogenous motoneuronal neurodegene...
Objective: To investigate and compare two ALS staging systems, King’s clinical staging and Milano-To...
International audienceBackground: Assessing clinical progression in amyotrophic lateral sclerosis (A...
Background and purpose: To compare two recently developed staging systems for amyotrophic lateral sc...
Background: Amyotrophic lateral sclerosis (ALS) shows considerable clinical heterogeneity, which aff...
Background: Amyotrophic lateral sclerosis (ALS) shows considerable clinical heterogeneity, which aff...
To investigate and compare two ALS staging systems, King's clinical staging and Milano-Torino (MiToS...
Objective: The choice of adequate proxy for long-term survival, the ultimate outcome in randomised c...
OBJECTIVE: Clinical stages in amyotrophic lateral sclerosis (ALS) can be measured using a simple sys...
Objective: It is important to explore the utility of clinical staging systems in the management of a...
International audienceAmyotrophic lateral sclerosis (ALS) is a heterogenous motoneuronal neurodegene...